Nov-Dec (In Press)                   Back to the articles list | Back to browse issues page

XML Print


1- MSc cancer research center,Golestan University of Medical Sciences, Gorgan,Iran, cancer research center,Golestan University of Medical Sciences, Gorgan,Iran
2- PhD cancer research center,Golestan University of Medical Sciences, Gorgan,Iran, cancer research center,Golestan University of Medical Sciences, Gorgan,Iran
3- MSc cancer research center,Tehran University of Medical Sciences, Tehran, Iran, cancer research center,Tehran University of Medical Sciences, Tehran, Iran
4- PhD Golestan University of Medical Sciences, Medical Laboratory Sciences Research Center, Gorgan, Iran, Golestan University of Medical Sciences, Medical Laboratory Sciences Research Center, Gorgan, Iran , Hr_joshaghani@yahoo.com
Abstract:   (71 Views)

Background and Objective: HER-2 (human epidermal growth factor receptor 2) is one such gene that can play a role in the development of breast cancer by making HER-2 proteins (receptorson breast cells). Normally, HER-2 receptors control breast cells grow and Division.  HER-2 protein over expression is the cause of up to 20% of breast cancers. The phosphoinositide 3 kinase (PI3K) pathway is important in the oncogenic function of HER-2. 

It has been reported compounds including Se, such as selenite significantly attenuated oxidative-stress-induced activation of the PI3K signaling pathways and can exhibit antitumor activity by downregulating PI3K activation.

 In this study, we evaluated Association of tissue selenium level and Human epidermal growth factor receptor 2 (HER-2) expression in breast cancer.

methods:

Se contents and expression of HER-2 were determined in 30 tissue collected from 30 women diagnosed with breast cancer based on immunohistochemistry (HER-2) and atomic absorption (Se).

Results:

About 30% of the samples were positive for HER-2 expression. Mean level of tissue selenium in tumors for positive and negative HER-2 was 268.15 µg/l and 206.43µg/l respectively. So, there was no significant association between selenium level and HER-2 expression. (p>0.005)

Conclusion:

There is no Association of tissue selenium level and HER-2 expression in breast cancer.

Keyword:

Selenium, HER-2, breast cancer

     
Type of Study: Original Paper | Subject: Special
Received: 2018/07/12 | Accepted: 2018/07/12 | Published: 2018/07/12

Add your comments about this article : Your username or Email:
CAPTCHA code

Send email to the article author


© 2007 All Rights Reserved | Medical Laboratory Journal